Evidence map›Paper›PMID 40485545›Full record

ArticleProteins2025

Structural Analysis of the SARS-CoV-2 Spike N-Terminal Domain Across Wild-Type and Recent Variants: A Comparative Study.

Miriana Quaranta, Allegra Via, Stefano Pascarella

Abstract readComparative Study
In one paragraph

Article in Proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miriana QuarantaDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.ORCID 0009-0003-0855-485X
Allegra ViaDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-3398-5462
Stefano PascarellaDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-6822-4022

Funding

Sapienza Università di Roma
6 · The paper itself

Abstract

Since its first appearance in China, the molecular evolution of SARS-CoV-2 has progressed through altering the properties of the Spike protein, changing the virus ability to transmit and to evade host immune surveillance. Despite receiving less attention than the Receptor Binding Domain (RBD), the Spike N-Terminal Domain (NTD) is crucial to SARS-CoV-2 biology and pathogenesis. This study provides a comparative structural analysis of the NTD from the wild-type strain and different variants (BA.2, XBB.1, XBB.1.5, BA.2.86, JN.1, HV.1, KP.2, KP.3, and KP.3.1.1), aiming to clarify the structural impact of mutations in each variant. To assess the impact of mutations on the interaction of NTD with antibodies, we selected as a test case the neutralizing antibody 4A8, which has proven highly effective against the WT. The results obtained from molecular dynamics simulations, surface electrostatic potential analysis, and binding energy predictions show a clear trend in the evolution of the virus. The net charge of the NTD decreases as the variants progress, reaching a minimum charge of -1.84 observed for KP.3.1.1. This is in clear contrast to the RBD net charge, which follows an opposite trend toward higher positive values. Binding energy predictions show that the antibody's efficacy decreases as the virus evolves. While the WT exhibited an interaction energy of -96.28 kcal/mol with 4A8, more recent variants like KP.3 show no interaction stronger than -64.00 kcal/mol. These results reveal a clear trend of modifications aimed at favoring immune escape in the virus' evolutionary trajectory.

Indexed as

SARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralCOVID-19HumansMolecular Dynamics SimulationMutationProtein BindingProtein DomainsStatic ElectricityAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-24A8electrostatic surfaceflexibilityinteraction energymolecular dynamicsNTDSARS‐CoV‐2

Identifiers

PMID40485545
PMCPMC12517252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.